Apheresis Equipment Market Is Projected To Be Around $2.57 Billion By 2022
Publish Date :
Request for Customization
A research study titled, “Apheresis Equipment Market by product Type - Global Industry Analysis and Forecast to 2022” published by Crystal Market Research, states that the apheresis equipment market is projected to be around $2.57 billion by 2022.
In 2012, the global apheresis equipment market was valued around USD 1.21 billion and is projected to reach approximately USD 2.57 billion by 2022, registering a compound annual growth rate (CAGR) of 7.05% during the forecast period. Apheresis is a process of blood element separation with the help of membrane filtration or centrifugation technology. This process exists since 1950’s and used for different blood component separation and blood purification purpose. The process is executed either for disease treatment by removing the disease-causing or diseased blood component or for blood component donation. Whole blood is drawn out from patient or donor’s body, refined by apheresis machine, and the preferred blood components are divided on the basis of their size, molecular weight, and resemblance to a specific material. The leftover blood is instilled back to patient or donor’s body. Apheresis processes are performed around the world for treatment of a variety of renal, neurological, autoimmune, hematological, and other disease.
The global apheresis equipment market is anticipated to demonstrate lucrative growth while maintaining a significant compound annual growth rate over the projected period of 2012 to 2022. Rising prevalence of blood-related diseases contributing to the increase in plasma and platelets demand is anticipated to assist the global market as an eminent impact rendering and growth driving factor. The global apheresis market is also projected to be fueled by technological advancements aimed at rendering comparatively more quick and effective results. Healthcare researchers and practitioners are now needed the devices which will require least human intervention and the advent of completely automatic apheresis equipment with superior displays is anticipated to enhance application rates for this equipment and hence boosting the global apheresis market over the forecast period. Risk of blood infection, deficiency of experts to execute the process and inaccessibility of both specific blood group & donor are the factors which might hinder the growth of the global market over the next few years.
The key market participants for the global apheresis equipment market are; Terumo BCT, Inc., Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., B. Braun Melsungen AG, HemaCare Corporation, Therakos, Inc., and others. According to the product type, the apheresis market is classified as; Apheresis machine and Disposable Apheresis kits. On the basis of the procedure, the global market industry is divided into; Plasmapheresis, Plateletpheresis, LDL-apheresis, Leukapheresis, Erythrocytapheresis, Photopheresis and Other Equipment. By application, the market is split as; Hematology, Renal Diseases, Neurology and Other Applications. Depending on the technology used, the market is split into; Centrifugation and Membrane Separation. Geographically, the global apheresis market is segmented into regions which are; Europe (Germany, Spain, Italy, France, UK and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), North America (the United States, Mexico and Canada)and Rest of the World (Brazil, Saudi Arabia, South Africa, United Arab Emirates and Others).
Browse full research report with TOC on “Apheresis Equipment Market by product Type - Global Industry Analysis and Forecast to 2022” at:
Key Findings of the Apheresis Equipment Market
- Rising blood-related disease occurrences contributing to blood components demand and Advancements in apheresis techniques are the factors boosting the market growth while lack of skilled workers for performing process, blood infection risk, lack of donors, and unavailability of particular blood group are the restraints for market growth.
- Existence of high unfulfilled needs and speedily increasing requirements for platelets in the developing Latin American and Asia Pacific markets is anticipated to assist global market as potential growth opportunities.
- Key players of this industry include Fresenius Kabi; Haemonetics; Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., B. Braun Melsungen AG, HemaCare Corporation, Therakos, Inc. Strategies encouraging rapid distribution and development of proficient supply chain are increasingly integrated by the market players.